RecruitingNCT04448951

Immune Homeostasis in Sepsis and Septic Shock

Immune Homeostasis in Patients With Sepsis and Septic Shock: a Single Center Observational Study

Sponsor

Charles University, Czech Republic

Enrollment

200 participants

Start Date

Sep 1, 2020

Study Type

OBSERVATIONAL

Conditions

Sepsis Immune Deficiency Immunologic Paralysis Immunologic Suppression

Summary

Detailed description of immune response and its dynamics in sepsis and septic shock patiens by means of transcriptomics, flow-cytometry and cytokine analysis.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying cytokines, flow-cytometry, and others for people with immune deficiency, immunologic paralysis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.